A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors (Q46948876)
Jump to navigation
Jump to search
scientific article published on 16 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors |
scientific article published on 16 October 2007 |
Statements
1 reference
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors (English)
1 reference
Keith Bible
1 reference
Elisabeth I Heath
1 reference
Robert E Martell
1 reference
Daniel C Adelman
1 reference
Patricia M Lorusso
1 reference
16 October 2007
1 reference
1 reference
26
1 reference
59-65
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference